2018 ESMO Congress

October 19-23, 2018
Munich, Germany

Poster presentation:

Circulating tumor DNA and RNA as an exploratory biomarker to evaluate GT0918 in a phase I/II clinical trial in mCRPC patients
https://academic.oup.com/annonc/article/29/suppl_8/mdy269.162/5141769?searchresult=1

Leave a Reply